Middle East & Africa Cellular Immunotherapy Market Size & Outlook
Related Markets
MEA cellular immunotherapy market highlights
- The MEA cellular immunotherapy market generated a revenue of USD 242.2 million in 2022.
- The market is expected to grow at a CAGR of 23.9% from 2023 to 2030.
- In terms of segment, car t cell therapy was the largest revenue generating therapy type in 2022.
- CAR T Cell Therapy is the most lucrative therapy type segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2023 to 2030.
MEA data book summary
| Market revenue in 2022 | USD 242.2 million |
| Market revenue in 2030 | USD 1,342.8 million |
| Growth rate | 23.9% (CAGR from 2022 to 2030) |
| Largest segment | Car t cell therapy |
| Fastest growing segment | CAR T Cell Therapy |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CAR T Cell Therapy, Dendritic Cell Therapy, NK Cell Therapy, TIL Therapy |
| Key market players worldwide | BioTelemetry, Biotricity Inc, Welch Allyn, Boston Scientific Corp, ZOLL Medical Corporation, IRhythm Technologies Inc, ACS Diagnostics, Medicomp, Telerhythmics |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.2% of the global cellular immunotherapy market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 9,288.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cellular Immunotherapy Market Scope
Cellular Immunotherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| ACS Diagnostics | View profile | 101-250 | Irvine, California, United States, North America | https://acsd4u.com/ |
| Telerhythmics | View profile | 51-100 | Collierville, Tennessee, United States, North America | http://telerhythmics.com |
| Medicomp | View profile | 101-250 | Melbourne, Florida, United States, North America | https://medicompinc.com/ |
| Biotricity Inc | View profile | 55 | 275 Shoreline Drive, Suite 150, Redwood City, CA, United States, 94065 | https://www.biotricity.com |
| IRhythm Technologies Inc | View profile | 2000 | 699 8th Street, Suite 600, San Francisco, CA, United States, 94103 | https://www.irhythmtech.com |
| ZOLL Medical Corporation | View profile | 1001-5000 | Chelmsford, Massachusetts, United States, North America | http://www.zoll.com/ |
| BioTelemetry | View profile | 1001-5000 | Malvern, Pennsylvania, United States, North America | https://www.gobio.com |
| Welch Allyn | View profile | 1001-5000 | Skaneateles Falls, New York, United States, North America | https://www.welchallyn.com/en.html |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
Middle East & Africa cellular immunotherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cellular immunotherapy market will help companies and investors design strategic landscapes.
Car t cell therapy was the largest segment with a revenue share of 72.5% in 2022. Horizon Databook has segmented the Middle East & Africa cellular immunotherapy market based on car t cell therapy, dendritic cell therapy, nk cell therapy, til therapy covering the revenue growth of each sub-segment from 2018 to 2030.
- Middle East & Africa Cellular Immunotherapy Therapy Type Outlook (Revenue, USD Million, 2018-2030)
- CAR T Cell Therapy
- Dendritic Cell Therapy
- NK Cell Therapy
- TIL Therapy
- Others
- Middle East & Africa Cellular Immunotherapy Indication Outlook (Revenue, USD Million, 2018-2030)
- B-cell Malignancies
- Prostate Cancer
- Liver Cancer
- Renal Cell Carcinoma
- Others
- Middle East & Africa Cellular Immunotherapy End Use Outlook (Revenue, USD Million, 2018-2030)
- Others
- Hospitals
- Cancer Institutes
Reasons to subscribe to Middle East & Africa cellular immunotherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa cellular immunotherapy market databook
-
Our clientele includes a mix of cellular immunotherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa cellular immunotherapy market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa cellular immunotherapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA cellular immunotherapy market size, by country, 2018-2030 (US$M)
Middle East & Africa Cellular Immunotherapy Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
